Enroll for MediPharm Solutions' Clinical Research and Data Management Certificate Course now and build a platform for a ...

An annual review of clinical trials for Alzheimer's disease highlights a growing number of active trials—and drugs—in the ...

Research findings suggest that a new blood test for Alzheimer’s disease has shown promise in accurately identifying people ...

At a panel at CTO West Coast, experts from biopharmaceutical companies outlined innovative strategies to shape the future of ...

Primary progressive aphasia is a neurological condition that causes a gradual decline in language abilities. There is no cure ...

Psychedelics research gains support from the Trump administration for treating PTSD and mental health conditions, with Veterans Affairs exploring treatments that show promise in clinical trials.

Luton, Bedfordshire, United Kingdom, June 05, 2025 (GLOBE NEWSWIRE) -- The global pediatric glioma drugs market is poised for substantial growth, with an estimated value of approximately USD 5 billion ...

Highlights from the 2025 Global Equine Endocrinology Symposium included never-before-presented study results on insulin ...

Almost a year after it welcomed its first patient for trial, Elon Musk's neurotechnology company Neuralink has recently ...

BioNet and Bio Farma partner to develop TdaP vaccines for ASEAN region, targeting 10-15 million doses annually worth $200 ...

A new study shows that colibactin exposure in the first decade imprints DNA changes that can accelerate colorectal cancer ...

Specialty televisits remain common in the Veterans Health Administration following the COVID-19 pandemic, suggesting they will remain an important ongoing care modality for many patients.